Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2022

09-09-2021 | Review

Outcomes of Endoscopic Submucosal Dissection for Treatment of Superficial Pharyngeal Cancers: Systematic Review and Meta-Analysis

Authors: Faisal Kamal, Muhammad Ali Khan, Wade Lee-Smith, Sachit Sharma, Zaid Imam, Dawit Jowhar, Ellen Petryna, Julia Esswein, Ashu Acharya, Muhammad Aziz, Umer Farooq, Usman Zafar, Stephanie Mcdonough, Douglas G. Adler

Published in: Digestive Diseases and Sciences | Issue 8/2022

Login to get access

Abstract

Background and Aims

Studies evaluating the role of endoscopic submucosal dissection (ESD) in the management of superficial pharyngeal cancers have reported promising results. This meta-analysis evaluates the efficacy and safety of ESD in the management of superficial pharyngeal cancers.

Methods

We reviewed several databases from inception to September 03, 2020, to identify studies evaluating the efficacy and safety of ESD in the management of superficial pharyngeal cancers. Our outcomes of interest were en bloc resection rate, complete resection rate, adverse events, and rates of local recurrence. Pooled rates with 95% confidence intervals (CI) for all outcomes were calculated using random-effect model. Heterogeneity was assessed by I2 statistic. We assessed publication bias by using funnel plots and Egger’s test. We conducted meta-regression analysis to explore heterogeneity in analyses.

Results

Ten studies were included in analyses. All studies were from Asia. Pooled rates (95% CI) for en bloc resection and complete resection were 94% (87%, 97%) and 72% (62%, 80%), respectively. The pooled rates (95% CI) for adverse events and local recurrence were 10% (5%, 17%) and 1.9% (0.9%, 4%), respectively. Most of the analyses were limited by substantial heterogeneity. On meta-regression analysis, the heterogeneity was explained by size of tumor and histology. Funnel plots and Egger’s test showed no evidence of publication bias.

Conclusions

This meta-analysis including studies from Asian countries demonstrated that ESD is an efficacious and safe option in the management of superficial pharyngeal cancers. More studies and studies from Western countries are needed to further validate these findings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Muto M, Minashi K, Yano T et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010;28:1566–1572.CrossRef Muto M, Minashi K, Yano T et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010;28:1566–1572.CrossRef
2.
go back to reference Nonaka S, Saito Y. Endoscopic diagnosis of pharyngeal carcinoma by NBI. Endoscopy 2008;40:347–351.CrossRef Nonaka S, Saito Y. Endoscopic diagnosis of pharyngeal carcinoma by NBI. Endoscopy 2008;40:347–351.CrossRef
3.
go back to reference Ugumori T, Muto M, Hayashi R, Hayashi T, Kishimoto S. Prospective study of early detection of pharyngeal superficial carcinoma with the narrowband Imaging laryngoscope. Head Neck 2009;31:189–194.CrossRef Ugumori T, Muto M, Hayashi R, Hayashi T, Kishimoto S. Prospective study of early detection of pharyngeal superficial carcinoma with the narrowband Imaging laryngoscope. Head Neck 2009;31:189–194.CrossRef
4.
go back to reference Muto M, Nakane M, Katada C et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer 2004;101:1375–1381.CrossRef Muto M, Nakane M, Katada C et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer 2004;101:1375–1381.CrossRef
5.
go back to reference Fang FM, Tsai WL, Chien CY et al. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation. Oncology 2005;68:405–413.CrossRef Fang FM, Tsai WL, Chien CY et al. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation. Oncology 2005;68:405–413.CrossRef
6.
go back to reference Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M. Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results. Otolaryngol Head Neck Surg 2001;124:561–569.CrossRef Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M. Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results. Otolaryngol Head Neck Surg 2001;124:561–569.CrossRef
7.
go back to reference Ngamruengphong S, Ferri L, Aihara H et al. Efficacy of endoscopic submucosal dissection for superficial gastric neoplasia in a large cohort in North America. Clin Gastroenterol Hepatol. 2021;19:1611–1619.CrossRef Ngamruengphong S, Ferri L, Aihara H et al. Efficacy of endoscopic submucosal dissection for superficial gastric neoplasia in a large cohort in North America. Clin Gastroenterol Hepatol. 2021;19:1611–1619.CrossRef
8.
go back to reference Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T et al. Endoscopic submucosal dissection: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 2015;47:829–854.CrossRef Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T et al. Endoscopic submucosal dissection: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 2015;47:829–854.CrossRef
9.
go back to reference Tate DJ, Klein A, Sidhu M et al. Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video). Gastrointest Endosc 2019;90:467–79 e4.CrossRef Tate DJ, Klein A, Sidhu M et al. Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video). Gastrointest Endosc 2019;90:467–79 e4.CrossRef
10.
go back to reference Iizuka T, Kikuchi D, Suzuki Y, Tanaka M, Takeda H. Clinical relevance of endoscopic treatment for superficial pharyngeal cancer: feasibility of techniques corresponding to each location and long-term outcomes. Gastrointestinal Endosc. 2020;93:818–827.CrossRef Iizuka T, Kikuchi D, Suzuki Y, Tanaka M, Takeda H. Clinical relevance of endoscopic treatment for superficial pharyngeal cancer: feasibility of techniques corresponding to each location and long-term outcomes. Gastrointestinal Endosc. 2020;93:818–827.CrossRef
11.
go back to reference Abe M, Iwamuro M, Kawahara Y et al. Clinicopathological features and outcomes of endoscopic submucosal dissection for superficial cancer of the pharynx. Acta Med Okayama 2019;73:109–115.PubMed Abe M, Iwamuro M, Kawahara Y et al. Clinicopathological features and outcomes of endoscopic submucosal dissection for superficial cancer of the pharynx. Acta Med Okayama 2019;73:109–115.PubMed
12.
go back to reference Okada K, Tsuchida T, Ishiyama A et al. Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas. Endoscopy 2012;44:556–564.CrossRef Okada K, Tsuchida T, Ishiyama A et al. Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas. Endoscopy 2012;44:556–564.CrossRef
13.
go back to reference Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003;73:712–716.CrossRef Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003;73:712–716.CrossRef
14.
go back to reference Vanella G, Crippa S, Archibugi L et al. Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation. Br J Surg 2018;105:328–338.CrossRef Vanella G, Crippa S, Archibugi L et al. Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation. Br J Surg 2018;105:328–338.CrossRef
15.
go back to reference Elkhadem A, Mickan S, Richards D. Adverse events of surgical extrusion in treatment for crown-root and cervical root fractures: a systematic review of case series/reports. Dent Traumatol 2014;30:1–14.CrossRef Elkhadem A, Mickan S, Richards D. Adverse events of surgical extrusion in treatment for crown-root and cervical root fractures: a systematic review of case series/reports. Dent Traumatol 2014;30:1–14.CrossRef
16.
go back to reference Lee JH, Chen KM, Chang CH, Liu YT, Yang CC. Endoscopic submucosal dissection for superficial pharyngeal squamous cell carcinoma. Adv Digest Med. 2021;8:33–39.CrossRef Lee JH, Chen KM, Chang CH, Liu YT, Yang CC. Endoscopic submucosal dissection for superficial pharyngeal squamous cell carcinoma. Adv Digest Med. 2021;8:33–39.CrossRef
17.
go back to reference Yoshio T, Tsuchida T, Ishiyama A et al. Efficacy of double-scope endoscopic submucosal dissection and long-term outcomes of endoscopic resection for superficial pharyngeal cancer. Gastroenterol Endosc. 2017;59:2750–2759. Yoshio T, Tsuchida T, Ishiyama A et al. Efficacy of double-scope endoscopic submucosal dissection and long-term outcomes of endoscopic resection for superficial pharyngeal cancer. Gastroenterol Endosc. 2017;59:2750–2759.
18.
go back to reference Kinjo Y, Nonaka S, Oda I et al. The short-term and long-term outcomes of the endoscopic resection for the superficial pharyngeal squamous cell carcinoma. Endosc Int Open. 2015;3:E266–E273.CrossRef Kinjo Y, Nonaka S, Oda I et al. The short-term and long-term outcomes of the endoscopic resection for the superficial pharyngeal squamous cell carcinoma. Endosc Int Open. 2015;3:E266–E273.CrossRef
19.
go back to reference Hanaoka N, Ishihara R, Takeuchi Y et al. Endoscopic submucosal dissection as minimally invasive treatment for superficial pharyngeal cancer: a phase II study (with video). Gastrointest Endosc 2015;82:1002–1008.CrossRef Hanaoka N, Ishihara R, Takeuchi Y et al. Endoscopic submucosal dissection as minimally invasive treatment for superficial pharyngeal cancer: a phase II study (with video). Gastrointest Endosc 2015;82:1002–1008.CrossRef
20.
go back to reference Hanaoka N, Ishihara R, Takeuchi Y et al. Clinical outcomes of endoscopic mucosal resection and endoscopic submucosal dissection as a transoral treatment for superficial pharyngeal cancer. Head Neck 2013;35:1248–1254.CrossRef Hanaoka N, Ishihara R, Takeuchi Y et al. Clinical outcomes of endoscopic mucosal resection and endoscopic submucosal dissection as a transoral treatment for superficial pharyngeal cancer. Head Neck 2013;35:1248–1254.CrossRef
21.
go back to reference Kuwabara T, Hiyama T, Oka S et al. Clinical features of pharyngeal intraepithelial neoplasias and outcomes of treatment by endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:1095–1103.CrossRef Kuwabara T, Hiyama T, Oka S et al. Clinical features of pharyngeal intraepithelial neoplasias and outcomes of treatment by endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:1095–1103.CrossRef
22.
go back to reference Shimizu Y, Yamamoto J, Kato M et al. Endoscopic submucosal dissection for treatment of early stage hypopharyngeal carcinoma. Gastrointest Endosc. 2006;64:255–259.CrossRef Shimizu Y, Yamamoto J, Kato M et al. Endoscopic submucosal dissection for treatment of early stage hypopharyngeal carcinoma. Gastrointest Endosc. 2006;64:255–259.CrossRef
23.
go back to reference Tateya I, Shiotani A, Satou Y et al. Transoral surgery for laryngo-pharyngeal cancer—the paradigm shift of the head and cancer treatment. Auris Nasus Larynx 2016;43:21–32.CrossRef Tateya I, Shiotani A, Satou Y et al. Transoral surgery for laryngo-pharyngeal cancer—the paradigm shift of the head and cancer treatment. Auris Nasus Larynx 2016;43:21–32.CrossRef
24.
go back to reference Weinstein GS, O’Malley BW Jr, Desai SC, Quon H. Transoral robotic surgery: does the ends justify the means? Curr Opin Otolaryngol Head Neck Surg 2009;17:126–131.CrossRef Weinstein GS, O’Malley BW Jr, Desai SC, Quon H. Transoral robotic surgery: does the ends justify the means? Curr Opin Otolaryngol Head Neck Surg 2009;17:126–131.CrossRef
25.
go back to reference Kishimoto Y, Tateya I, Funakoshi M, Miyamoto SI, Muto M, Omori K. Endoscopic laryngopharyngeal surgery for hypopharyngeal lesions. Oral Oncol 2020;106:104655.CrossRef Kishimoto Y, Tateya I, Funakoshi M, Miyamoto SI, Muto M, Omori K. Endoscopic laryngopharyngeal surgery for hypopharyngeal lesions. Oral Oncol 2020;106:104655.CrossRef
26.
go back to reference Tateya I, Muto M, Morita S et al. Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer. Surg Endosc 2016;30:323–329.CrossRef Tateya I, Muto M, Morita S et al. Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer. Surg Endosc 2016;30:323–329.CrossRef
Metadata
Title
Outcomes of Endoscopic Submucosal Dissection for Treatment of Superficial Pharyngeal Cancers: Systematic Review and Meta-Analysis
Authors
Faisal Kamal
Muhammad Ali Khan
Wade Lee-Smith
Sachit Sharma
Zaid Imam
Dawit Jowhar
Ellen Petryna
Julia Esswein
Ashu Acharya
Muhammad Aziz
Umer Farooq
Usman Zafar
Stephanie Mcdonough
Douglas G. Adler
Publication date
09-09-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07225-6

Other articles of this Issue 8/2022

Digestive Diseases and Sciences 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.